
Teva’s quiet layoff announcement reveals bold restructuring plan
Teva Pharmaceuticals offered a long-awaited explanation for the sharp 10% jump in its share price last week. But the gains come at a steep human cost. The Israeli drugmaker reassured investors with a revised, more optimistic profit forecast—after a …